Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Mar 31, 2025 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -10.64%8.36B | 6.28%9.36B | -4.29%2.15B | 2.07%2.29B | 5.48%2.43B | 23.66%2.49B | -0.47%8.8B | -12.00%2.24B | -0.85%2.25B | 7.55%2.3B |
| Cost of revenue | -15.40%5.65B | 10.32%6.67B | 15.32%1.82B | 5.37%1.55B | -2.46%1.66B | 26.60%1.64B | -5.00%6.05B | -14.71%1.58B | -14.35%1.47B | 11.60%1.7B |
| Gross profit | 1.22%2.71B | -2.62%2.68B | -50.99%325.03M | -4.18%742.37M | 27.85%771.37M | 18.31%842.8M | 11.19%2.75B | -4.79%663.23M | 41.46%774.78M | -2.42%603.32M |
| Operating expense | 2.89%1.83B | 12.17%1.78B | 41.11%525.61M | 0.58%398.67M | 8.52%466.26M | 0.20%386.97M | 13.83%1.58B | -2.42%372.47M | 16.07%396.38M | 29.30%429.63M |
| Operating profit | -2.08%885.31M | -22.67%904.07M | -168.99%-200.58M | -9.17%343.7M | 75.67%305.12M | 39.75%455.83M | 7.80%1.17B | -7.67%290.76M | 83.53%378.4M | -39.27%173.69M |
| Net non-operating interest income (expenses) | -26.43%-46.65M | -53.02%-36.9M | 25.94%-5.27M | -20.21%-10.27M | -65.21%-10.5M | -416.36%-10.86M | -40.51%-24.11M | -157.40%-7.11M | -79.65%-8.54M | -31.04%-6.36M |
| Non-operating interest income | 29.11%46.31M | 53.41%35.87M | 61.59%12.99M | 61.03%7.9M | 29.80%7.67M | 61.47%7.31M | 78.03%23.38M | 91.77%8.04M | 30.06%4.91M | 135.82%5.91M |
| Non-operating interest expense | 27.75%92.95M | 53.21%72.76M | 20.50%18.26M | 35.11%18.17M | 48.15%18.18M | 174.09%18.16M | 56.78%47.49M | 117.84%15.15M | 57.71%13.45M | 66.73%12.27M |
| Net investment income | -161.83%-241.85M | 60.15%391.14M | 4,875.71%47.52M | 146.73%98.41M | -58.97%62.03M | -39.48%183.19M | -13.92%244.24M | -99.29%955K | -379.54%-210.6M | 376.96%151.2M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 200.5M | 0 | -96.78%58K | |||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | -97.82%39.1M | 1,584.50%1.79B | 14,091.10%1.7B | -69.85%89.09M | 99.43%-2.46M | -89.87%715K | -123.19%-120.61M | 269.24%12M | 19,352.77%295.53M | -862.85%-435.2M |
| Less:Restructuring and mergern&acquisition | ---- | --0 | --0 | ---- | ---- | ---- | --3.45M | ---244.76M | ---9.18M | ---- |
| Less:Other special charges | 97.82%-39.1M | -1,628.21%-1.79B | -831.70%-1.7B | 68.89%-89.09M | -98.62%2.46M | 89.87%-715K | 143.75%117.16M | 20,756.27%232.76M | -18,754.46%-286.35M | 293.38%177.81M |
| Other non-operating income (expenses) | 190.35%52.3M | 122.14%18.01M | 109.93%5.96M | 112.70%3.71M | 39.01%5.68M | -28.23%2.67M | -3,406.03%-81.38M | -418.81%-60.01M | -32.91%-29.17M | 138.41%4.09M |
| Income before tax | -71.02%888.71M | 158.31%3.07B | 555.27%1.55B | 23.27%524.64M | 419.64%359.86M | -0.94%631.55M | -8.43%1.19B | -48.54%236.65M | 68.04%425.62M | -143.80%-112.58M |
| Income tax | -70.46%258.23M | 183.20%874.05M | 3,734.01%501.14M | -38.86%75.03M | 775.03%105.03M | 2.35%192.85M | -17.44%308.63M | -85.46%13.07M | 34.16%122.71M | -116.76%-15.56M |
| Net income | -71.25%630.49M | 149.57%2.19B | 369.43%1.05B | 48.43%449.61M | 362.65%254.84M | -2.32%438.7M | -4.77%878.6M | -39.56%223.58M | 87.20%302.91M | -159.10%-97.02M |
| Net income continuous operations | -71.25%630.49M | 149.57%2.19B | 369.43%1.05B | 48.43%449.61M | 362.65%254.84M | -2.32%438.7M | -4.77%878.61M | -39.56%223.58M | 87.20%302.91M | -159.10%-97.02M |
| Noncontrolling interests | -108.88%-62K | 88.14%698K | 9.64%364K | 90.70%-24K | 300.00%268K | -60.87%90K | 144.06%371K | 253.70%332K | -43.33%-258K | 107.49%67K |
| Net income attributable to the company | -71.23%630.55M | 149.59%2.19B | 369.97%1.05B | 48.31%449.63M | 362.19%254.57M | -2.29%438.61M | -4.90%878.23M | -39.69%223.25M | 87.15%303.17M | -158.82%-97.09M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -71.23%630.55M | 149.59%2.19B | 369.97%1.05B | 48.31%449.63M | 362.19%254.57M | -2.29%438.61M | -4.90%878.23M | -39.69%223.25M | 87.15%303.17M | -158.82%-97.09M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -71.36%339.29 | 157.71%1.18K | 378.46%566.73 | 53.89%242.76 | 368.23%137.28 | 1.38%237.91 | -4.93%459.69 | -38.83%118.45 | 86.38%157.75 | -159.30%-51.18 |
| Diluted earnings per share | -71.36%339.29 | 157.71%1.18K | 378.00%566.1931 | 53.81%242.643 | 368.23%137.28 | 1.38%237.91 | -4.93%459.69 | -38.78%118.45 | 86.38%157.75 | -159.30%-51.18 |
| Dividend per share | 0.00%110 | 37.50%110 | 37.50%110 | 0 | 0 | 0 | 14.29%80 | 14.29%80 | 0 | 0 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |